ReviewFrontiers in public health2026
Data gaps for symptoms of myocardial infarction in transgender and gender diverse patients: a brief literature review and call to action.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease is the leading cause of death in the United States and has garnered several avenues of efforts to reduce incidence and mortality in patient populations. There has also been an increase in reported populations of transgender and gender diverse individuals as well as a reported increased risk for cardiovascular disease in this population. Despite this, there is no current research assessing warning signs of myocardial infarction and no standard of care exists for educating transgender and gender diverse individuals regarding their heart health. This article reviews the known literature on interactions between gender affirming hormone therapy and cardiovascular disease and highlights the need for more research of myocardial infarction onset symptoms in transgender and gender diverse populations to provide better heart health education and care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.